Abstract 3298: Neotargeting HER2 negative cancer cells with Trastuzumab-based photoimmunotherapy by viral transduction of HER2-extracellular domain

MLA

Michihiro Ishida, et al. “Abstract 3298: Neotargeting HER2 Negative Cancer Cells with Trastuzumab-Based Photoimmunotherapy by Viral Transduction of HER2-Extracellular Domain.” Cancer Research, vol. 73, Apr. 2013, p. 3298. EBSCOhost, https://doi.org/10.1158/1538-7445.am2013-3298.

APA

Michihiro Ishida, Kazuhiro Noma, Hisataka Kobayashi, Kyoko Shimoyama, Shunsuke Kagawa, Junji Matsuoka, Yuuri Hashimoto, Shinichiro Watamabe, Toshiyoshi Fujiwara, & Hiroshi Tazawa. (2013). Abstract 3298: Neotargeting HER2 negative cancer cells with Trastuzumab-based photoimmunotherapy by viral transduction of HER2-extracellular domain. Cancer Research, 73, 3298. https://doi.org/10.1158/1538-7445.am2013-3298

Chicago

Michihiro Ishida, Kazuhiro Noma, Hisataka Kobayashi, Kyoko Shimoyama, Shunsuke Kagawa, Junji Matsuoka, Yuuri Hashimoto, Shinichiro Watamabe, Toshiyoshi Fujiwara, and Hiroshi Tazawa. 2013. “Abstract 3298: Neotargeting HER2 Negative Cancer Cells with Trastuzumab-Based Photoimmunotherapy by Viral Transduction of HER2-Extracellular Domain.” Cancer Research 73 (April): 3298. doi:10.1158/1538-7445.am2013-3298.